Southwest Securities released a research report on April 12 stating that it gave Australian and Chinese endoscopy (688212.SH) a purchase rating, and the target price was 67.2 yuan. The main reasons for the rating include: 1) gross margin rebounded sharply after the epidemic in 23 years, and the volume of high-end products continued to be released; 2) the AQ-300 continued iteration, and various types of lenses continued to be enriched; 3) domestic soft mirror equipment leaders are expected to benefit from import substitution, and the AQ-300 release is imminent. (Mainichi Keizai Shimbun)